Skip To Content

News & Events

Given the activity level of our attorneys, we are confident in showcasing the various matters that our clients have given us the privilege to work on and approved to post here.

Posts

  • February 14 2024

    CERo Therapeutics, Inc., an immunotherapy company seeking to advance the next generation of engineered T cell therapeutics that employ phagocytic mechanisms, announced the closing of its business combination with Phoenix Biotech Acquisition Corp.  The transaction is valued at approximately $50,000,000.  EGS acted as counsel to CERo Therapeutics, Inc.

  • February 14 2024

    Aprea Therapeutics, Inc. announced the commencement of its At The Market Offering in the amount of $1,000,000. EG&S acted as counsel to the Sales Agent.

  • February 13 2024

    FSD Pharma Inc. announced the commencement of its At The Market Offering in the amount of $11,930,350. EG&S acted as counsel to the Sales Agent.

  • February 12 2024

    Client Alert: New York Credit Card Surcharge Law Updated

    On December 13, 2023, Governor Kathy Hochul signed a bill updating and clarifying New York’s credit card surcharge rules. This law is now in effect and businesses must comply with the updated credit card surcharge requirements.

    Click here to read the alert.

  • February 12 2024 Event

    Webinar | Navigating Legitimate Fees: Legal Billing Practices for Restaurants

    Amanda Fugazy, a member of the Firm, was invited by the New York State Restaurant Association to present  in their webinar – Navigating Legitimate Fees: Legal Billing Practices for Restaurants.  Ms. Fugazy will be guiding attendees through the legal landscape surrounding fees, including service charges, gratuity, credit card fees and other applicable charges. Stay informed and ensure your restaurant operates within the bounds of the law while providing exceptional service to your customers.

    Click here for more information.

  • February 12 2024

    ToughBuilt Industries, Inc. announced the closing of its Public Offering in the amount of $3,500,000. EG&S acted as counsel to the Placement Agent.

  • February 11 2024

    Energous Corporation announced the closing of its Registered Direct offering in the amount of $2,000,000. EG&S acted as counsel to the Placement Agent.

  • February 10 2024

    Revelation Biosciences, Inc. announced the closing of its Public Offering in the amount of $6,200,000. EG&S acted as counsel to the Placement Agent.

“It’s with genuine appreciation to all of our clients that we are in a position to achieve and maintain our leadership position in so many areas.”